T. Asakawa

Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

Toyoaki Hida, Hiroshi Nokihara, Masashi Kondo et al. · The Lancet · 2017 · 912 citations

Medicine, Oncology, Pharmacology +14

A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

Kenji Suzuki, Teruaki Koike, T. Asakawa et al. · Journal of Thoracic Oncology · 2011 · 657 citations · Full text

Medicine, Oncology, Radiology +10

Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato et al. · Nature Medicine · 2021 · 244 citations · Full text

Medicine, Molecular Medicine, Oncology +17

The CDF-II detector: Technical design report

R. E. Blair, Owen Rosser Long, W. Yao et al. · CERN Document Server (European Organization for Nuclear Research) · 1996 · 229 citations

Engineering, Nuclear Engineering, Radiation Detection +13

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

Hiroaki Okamoto, Kenji Watanabe, Hiroshi Kunikane et al. · British Journal of Cancer · 2007 · 212 citations · Full text

Medicine, Oncology, Pharmacology +15